Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the Pediatric Vaccine Market, and What Are the Key Drivers?

In recent times, there has been a significant growth in the size of the pediatric vaccine market. It is predicted to surge from $45.9 billion in 2024 to approximately $51.56 billion in 2025, attaining a compound annual growth rate (CAGR) of 12.3%. The previous growth period’s expansion can be linked to the heightened occurrence of chronic illnesses, the implementation of immunization policies to eliminate widespread diseases, and increased resources dedicated to vaccine development.

In the coming years, the pediatric vaccine market is projected to experience significant growth, with its value anticipated to reach $85.3 billion in 2029, indicating a compound annual growth rate (CAGR) of 13.4%. This expected growth during the forecast period is primarily due to the rise in cases of invasive cervical cancer, the robust state of late-stage pipeline and new drug approvals, and the increased prevalence of infectious diseases. The key trends for the forecast period include developing combination vaccines to cater to market demands, emphasizing the investment in R&D activities for creating effective vaccines, focusing on the production of live attenuated vaccines, employing cutting-edge immune engineering and advanced delivery systems, and integrating artificial intelligence (AI) into the vaccine development process to streamline it and enhance its manufacturing efficiency.

Which Primary Drivers Are Supporting the Continued Expansion of the pediatric vaccine Market?

The pediatric vaccines market is driven by the escalating occurrence of chronic illnesses like tuberculosis, diphtheria, and pneumonia amongst children and adolescents aged 15 and below. Kids and teenagers with chronic conditions are at a higher risk of severe health consequences and complications from infectious diseases. In March 2022, the Australian Bureau of Statistics, the self-regulating statutory agency in Australia responsible for collecting, analyzing, and providing factual advice, confirmed that nearly half of the country’s total population (46.6%, which equates to 11.6 million people) suffered from at least one chronic condition. With the heightened incidence of chronic diseases in children, the need for immunization against such diseases also increased, thus fueling the growth of the pediatric vaccines market.

Explore Comprehensive Insights Into The Global Pediatric Vaccine Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Companies Are Leading the Charge in Expanding the Pediatric Vaccine Market?

Major companies operating in the pediatric vaccine market include:

• Merck & Co. Inc._x000D_

• Serum Institute of India Pvt. Ltd._x000D_

• Sanofi SA_x000D_

• Pfizer Inc._x000D_

• AstraZeneca_x000D_

What New Trends Are Reshaping the Pediatric Vaccine Market and Its Opportunities?

The requirement for innovative vaccines is consistently on the rise to offer enhanced protection against complex infectious diseases, such as tuberculosis and HIV/ AIDS, as well as chronic non-communicable illnesses like cancer and neurodegenerative diseases. Modern vaccination development strategies encompass structural immunogenic design, gene-based vaccine platforms and potent adjuvant recombinant antigen formulations. In view of this growing need for new vaccines, pediatric vaccine manufacturers and developers are persistently seeking advancements in vaccine design and production technologies. Reflecting this demand, Pfizer Inc., a pharmaceutical firm based in the US, announced in April 2023 that the U.S. FDA had approved REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants.

Secure Your Global Pediatric Vaccine Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Key Segments of the Pediatric Vaccine Market Are Poised for Growth and Innovation?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

What Are the Top Regions Fueling Growth in the Pediatric Vaccine Market?

North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Pediatric Vaccine Market Defined Across Different Regions?

Pediatric vaccines refer to medications that are typically given to children as a form of protection against serious, frequently fatal diseases. They get the children’s body ready to battle the disease more quickly and successfully by boosting its natural defenses.

Browse Through More Similar Reports By The Business Research Company:

Anesthesia Disposables Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Hearing Aid Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hearing-aid-devices-and-equipment-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: